Form 4: Allovir CEO Diana Brainard Sells Shares to Cover Tax Obligations

Allovir's CEO, Diana Brainard, sold shares of common stock on July 19, 2024, to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• On July 19, 2024, Diana Brainard, the CEO of Allovir, Inc., sold 9,731 shares of common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $0.7501, with individual transactions ranging from $0.7343 to $0.7925.
• Following the transaction, Brainard still beneficially owns 773,251 shares of Allovir common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale of shares to cover tax obligations and doesn't inherently reflect a positive or negative outlook on the company.

Industry Context

Sales of shares by company executives are a common occurrence, often related to compensation and tax obligations. The sale itself doesn't necessarily indicate a negative outlook on the company's future, but it's a transaction investors often monitor.

Stakeholder Impact

• The sale of shares could have a minor impact on shareholders due to the slight dilution of equity.
• The impact on other stakeholders (employees, customers, suppliers, creditors) is likely negligible.

Key Dates